SCHOTT Pharma AG & Co. KGaA (SHTPY)
6.55
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
SCHOTT Pharma Cash from Investing (Quarterly) : -56.48M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.48M |
| March 31, 2026 | -16.16M |
| December 31, 2025 | -50.87M |
| September 30, 2025 | -82.13M |
| June 30, 2025 | -47.17M |
| March 31, 2025 | 9.989M |
| December 31, 2024 | -63.54M |
| September 30, 2024 | -188.57M |
| Date | Value |
|---|---|
| June 30, 2024 | -25.96M |
| March 31, 2024 | -31.34M |
| December 31, 2023 | -30.76M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -20.66M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | -43.20M |
| Drägerwerk AG & Co. KGaA | -31.18M |
| Sartorius AG | -175.22M |
| Reflect Scientific, Inc. | 0.00 |
| Ottobock SE & Co. KGaA | -160.52M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 53.57M |
| Cash from Financing (Quarterly) | -0.9728M |
| Free Cash Flow | 65.97M |
| Free Cash Flow Per Share (Quarterly) | 0.0258 |
| Free Cash Flow to Equity (Quarterly) | 15.55M |
| Free Cash Flow to Firm (Quarterly) | 18.87M |
| Free Cash Flow Yield | 1.67% |